As LXRα is a positive regulator of hyperglycemia and hepatic fatty acid synthesis67, expression of lipogenic genes, such as Srepb-1c, Fas, and Accα, is diminished and the antilipogenic effects of RORα have been validated in HFD-induced fatty liver. The gene discussed is NR1H3; the disease is fatty liver disease.